Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
Recruiting
Observational Study
Systemic Sclerosis (SSc)
Scleroderma
Scleroderma (Limited and Diffuse)
Scleroderma, Localized
Swallowing
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 7 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Hacettepe University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults di…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
For a child diagnosed with scleroderma:
Inclusion Criteria:
* Cases diagnosed with scleroderma,
* Cases aged 7-18 years will be included.
Exclusion Criteria:
* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Cases that are not willing to participate in the stud…
Contacts